| Autor: |
Chuliber FA; Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires., Schutz NP; Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires., Viñuales ES; Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires., Penchasky DL; Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires., Otero V; Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires., Villagra Iturre MJ; Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires., López MS; Section of Hematology and Hemostasis, Department of Applied Biochemistry, Central Laboratory, Hospital Italiano de Buenos Aires, Instituto universitario del Hospital Italiano, Buenos Aires, Argentina., Mezzarobba D; Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires., Barrera LH; Section of Hematology and Hemostasis, Department of Applied Biochemistry, Central Laboratory, Hospital Italiano de Buenos Aires, Instituto universitario del Hospital Italiano, Buenos Aires, Argentina., Privitera V; Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires., Arbelbide JA; Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires., Martinuzzo ME; Section of Hematology and Hemostasis, Department of Applied Biochemistry, Central Laboratory, Hospital Italiano de Buenos Aires, Instituto universitario del Hospital Italiano, Buenos Aires, Argentina. |
| Abstrakt: |
: Factor XIII (FXIII) levels may decrease because of surgical consumption. Acquired FXIII deficiency could be a cause of postoperative hemorrhage usually underdiagnosed in clinical practice. To determine the diagnosis confirmation rate of acquired FXIII deficiency in postsurgical patients with clinical suspicion and to compare the characteristics and evolution of patients with or without FXIII deficiency. We performed a retrospective cohort study, which included 49 inpatients who were attended at our university hospital from 2014 to 2018 with suspicion of acquired FXIII deficiency because of disproportionate postoperative hemorrhage. FXIIIA levels less than 50% was considered a deficiency. Persistence of bleeding for more than 48 h, drop in hematocrit points, red blood cells transfused units, hemoglobin levels 12-36 h after bleeding, and time elapsed from the procedure to the bleeding were assessed as outcome variables. Logistic regression was employed for both univariate and multivariate analyses. Of the 49 patients included, 27(55%) had FXIII deficiency, with a median level of 34% [interquartile range (IQR) 19-42]. Abdominal surgery was the most common [n = 21 (43%)]. All patients had routine coagulation tests within the hemostatic range. FXIII deficiency was associated with a drop of more than 4 points in hematocrit [OR 59.69 (95% CI 4.71-755.30)], red blood transfused units >2 [OR 45.38 (95% CI 3.48-590.65)], and delayed bleeding >36 h after surgery [OR 100.90 (95% CI 3.78-2695.40)]. Plasma-derived FXIII concentrate was administered to eight patients with life-threatening bleeding with resolution within 24 h. Only one deficient patient died from bleeding. FXIII levels were measured 15 days after diagnosis or more in 20 out of 27 deficient patients, with normal results. Acquired FXIII deficiency may be a frequent underdiagnosed entity that should be considered when high-volume and delayed postoperative hemorrhage is present in patients with hemostatic routine coagulation test results. |
